デフォルト表紙
市場調査レポート
商品コード
997529

医薬品添加剤の世界市場

Pharmaceutical Excipients

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 180 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=136.22円
医薬品添加剤の世界市場
出版日: 2021年04月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の医薬品添加剤の市場規模は、分析期間(2020年~2027年)に4.5%のCAGRで成長する見通しで、2020年の66億米ドルから、2027年には90億米ドルに達すると予測されています。

当レポートで分析されているセグメントの1つである有機化学品は、分析期間中に4.9%のCAGRで成長し、73億米ドルに達すると予測されています。

当レポートは、世界の医薬品添加剤市場について調査しており、Covid-19の影響、動向や成長要因、地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

調査対象企業の例

  • Archer Daniels Midland Company
  • Ashland Global Holdings Inc.
  • Associated British Foods PLC
  • BASF SE
  • Croda International PLC
  • DowDuPont, Inc.
  • Evonik Industries AG
  • Innophos Holdings, Inc.
  • Kerry Group PLC
  • Roquette
  • Signet Chemical Corporation Pvt. Ltd.
  • The Lubrizol Corporation
  • Wacker Chemie AG

目次

I. 調査手法

II. エグゼクティブサマリー

  • 市場概要
    • インフルエンサー市場の洞察
    • 世界市場の軌跡
    • Covid-19の影響と迫り来る世界の景気後退
  • 主要企業
  • 動向と推進要因
  • 世界市場の見通し

III. 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

IV. 競合

  • 企業プロファイル:42社
目次
Product Code: MCP13954

Abstract:

Global Pharmaceutical Excipients Market to Reach $9 Billion by 2027

Amid the COVID-19 crisis, the global market for Pharmaceutical Excipients estimated at US$6.6 Billion in the year 2020, is projected to reach a revised size of US$9 Billion by 2027, growing at a CAGR of 4.5% over the analysis period 2020-2027. Organic Chemicals, one of the segments analyzed in the report, is projected to record a 4.9% CAGR and reach US$7.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Inorganic Chemicals segment is readjusted to a revised 3.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.9 Billion, While China is Forecast to Grow at 4.2% CAGR

The Pharmaceutical Excipients market in the U.S. is estimated at US$1.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 4.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.4% and 3.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Other Types Segment to Record 1.6% CAGR

In the global Other Types segment, USA, Canada, Japan, China and Europe will drive the 1.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$246 Million in the year 2020 will reach a projected size of US$275.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1 Billion by the year 2027.

Select Competitors (Total 42 Featured) -

  • Archer Daniels Midland Company
  • Ashland Global Holdings Inc.
  • Associated British Foods PLC
  • BASF SE
  • Croda International PLC
  • DowDuPont, Inc.
  • Evonik Industries AG
  • Innophos Holdings, Inc.
  • Kerry Group PLC
  • Roquette
  • Signet Chemical Corporation Pvt. Ltd.
  • The Lubrizol Corporation
  • Wacker Chemie AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Pharmaceutical Excipients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Pharmaceutical Excipients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Pharmaceutical Excipients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Organic Chemicals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Organic Chemicals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Organic Chemicals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Inorganic Chemicals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Inorganic Chemicals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Inorganic Chemicals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Topical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Parenteral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Other Formulations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Other Formulations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Other Formulations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 25: USA Current & Future Analysis for Pharmaceutical Excipients by Type - Organic Chemicals, Inorganic Chemicals and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 26: USA Historic Review for Pharmaceutical Excipients by Type - Organic Chemicals, Inorganic Chemicals and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 27: USA 15-Year Perspective for Pharmaceutical Excipients by Type - Percentage Breakdown of Value Sales for Organic Chemicals, Inorganic Chemicals and Other Types for the Years 2012, 2020 & 2027
    • TABLE 28: USA Current & Future Analysis for Pharmaceutical Excipients by Formulation - Oral, Topical, Parenteral and Other Formulations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 29: USA Historic Review for Pharmaceutical Excipients by Formulation - Oral, Topical, Parenteral and Other Formulations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 30: USA 15-Year Perspective for Pharmaceutical Excipients by Formulation - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral and Other Formulations for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 31: Canada Current & Future Analysis for Pharmaceutical Excipients by Type - Organic Chemicals, Inorganic Chemicals and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Canada Historic Review for Pharmaceutical Excipients by Type - Organic Chemicals, Inorganic Chemicals and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 33: Canada 15-Year Perspective for Pharmaceutical Excipients by Type - Percentage Breakdown of Value Sales for Organic Chemicals, Inorganic Chemicals and Other Types for the Years 2012, 2020 & 2027
    • TABLE 34: Canada Current & Future Analysis for Pharmaceutical Excipients by Formulation - Oral, Topical, Parenteral and Other Formulations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Canada Historic Review for Pharmaceutical Excipients by Formulation - Oral, Topical, Parenteral and Other Formulations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 36: Canada 15-Year Perspective for Pharmaceutical Excipients by Formulation - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral and Other Formulations for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 37: Japan Current & Future Analysis for Pharmaceutical Excipients by Type - Organic Chemicals, Inorganic Chemicals and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Japan Historic Review for Pharmaceutical Excipients by Type - Organic Chemicals, Inorganic Chemicals and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 39: Japan 15-Year Perspective for Pharmaceutical Excipients by Type - Percentage Breakdown of Value Sales for Organic Chemicals, Inorganic Chemicals and Other Types for the Years 2012, 2020 & 2027
    • TABLE 40: Japan Current & Future Analysis for Pharmaceutical Excipients by Formulation - Oral, Topical, Parenteral and Other Formulations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Japan Historic Review for Pharmaceutical Excipients by Formulation - Oral, Topical, Parenteral and Other Formulations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 42: Japan 15-Year Perspective for Pharmaceutical Excipients by Formulation - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral and Other Formulations for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 43: China Current & Future Analysis for Pharmaceutical Excipients by Type - Organic Chemicals, Inorganic Chemicals and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: China Historic Review for Pharmaceutical Excipients by Type - Organic Chemicals, Inorganic Chemicals and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 45: China 15-Year Perspective for Pharmaceutical Excipients by Type - Percentage Breakdown of Value Sales for Organic Chemicals, Inorganic Chemicals and Other Types for the Years 2012, 2020 & 2027
    • TABLE 46: China Current & Future Analysis for Pharmaceutical Excipients by Formulation - Oral, Topical, Parenteral and Other Formulations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 47: China Historic Review for Pharmaceutical Excipients by Formulation - Oral, Topical, Parenteral and Other Formulations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 48: China 15-Year Perspective for Pharmaceutical Excipients by Formulation - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral and Other Formulations for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 49: Europe Current & Future Analysis for Pharmaceutical Excipients by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 50: Europe Historic Review for Pharmaceutical Excipients by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 51: Europe 15-Year Perspective for Pharmaceutical Excipients by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 52: Europe Current & Future Analysis for Pharmaceutical Excipients by Type - Organic Chemicals, Inorganic Chemicals and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Europe Historic Review for Pharmaceutical Excipients by Type - Organic Chemicals, Inorganic Chemicals and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 54: Europe 15-Year Perspective for Pharmaceutical Excipients by Type - Percentage Breakdown of Value Sales for Organic Chemicals, Inorganic Chemicals and Other Types for the Years 2012, 2020 & 2027
    • TABLE 55: Europe Current & Future Analysis for Pharmaceutical Excipients by Formulation - Oral, Topical, Parenteral and Other Formulations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Europe Historic Review for Pharmaceutical Excipients by Formulation - Oral, Topical, Parenteral and Other Formulations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 57: Europe 15-Year Perspective for Pharmaceutical Excipients by Formulation - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral and Other Formulations for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 58: France Current & Future Analysis for Pharmaceutical Excipients by Type - Organic Chemicals, Inorganic Chemicals and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 59: France Historic Review for Pharmaceutical Excipients by Type - Organic Chemicals, Inorganic Chemicals and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 60: France 15-Year Perspective for Pharmaceutical Excipients by Type - Percentage Breakdown of Value Sales for Organic Chemicals, Inorganic Chemicals and Other Types for the Years 2012, 2020 & 2027
    • TABLE 61: France Current & Future Analysis for Pharmaceutical Excipients by Formulation - Oral, Topical, Parenteral and Other Formulations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 62: France Historic Review for Pharmaceutical Excipients by Formulation - Oral, Topical, Parenteral and Other Formulations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 63: France 15-Year Perspective for Pharmaceutical Excipients by Formulation - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral and Other Formulations for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 64: Germany Current & Future Analysis for Pharmaceutical Excipients by Type - Organic Chemicals, Inorganic Chemicals and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Germany Historic Review for Pharmaceutical Excipients by Type - Organic Chemicals, Inorganic Chemicals and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 66: Germany 15-Year Perspective for Pharmaceutical Excipients by Type - Percentage Breakdown of Value Sales for Organic Chemicals, Inorganic Chemicals and Other Types for the Years 2012, 2020 & 2027
    • TABLE 67: Germany Current & Future Analysis for Pharmaceutical Excipients by Formulation - Oral, Topical, Parenteral and Other Formulations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Germany Historic Review for Pharmaceutical Excipients by Formulation - Oral, Topical, Parenteral and Other Formulations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 69: Germany 15-Year Perspective for Pharmaceutical Excipients by Formulation - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral and Other Formulations for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 70: Italy Current & Future Analysis for Pharmaceutical Excipients by Type - Organic Chemicals, Inorganic Chemicals and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Italy Historic Review for Pharmaceutical Excipients by Type - Organic Chemicals, Inorganic Chemicals and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 72: Italy 15-Year Perspective for Pharmaceutical Excipients by Type - Percentage Breakdown of Value Sales for Organic Chemicals, Inorganic Chemicals and Other Types for the Years 2012, 2020 & 2027
    • TABLE 73: Italy Current & Future Analysis for Pharmaceutical Excipients by Formulation - Oral, Topical, Parenteral and Other Formulations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Italy Historic Review for Pharmaceutical Excipients by Formulation - Oral, Topical, Parenteral and Other Formulations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 75: Italy 15-Year Perspective for Pharmaceutical Excipients by Formulation - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral and Other Formulations for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 76: UK Current & Future Analysis for Pharmaceutical Excipients by Type - Organic Chemicals, Inorganic Chemicals and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 77: UK Historic Review for Pharmaceutical Excipients by Type - Organic Chemicals, Inorganic Chemicals and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 78: UK 15-Year Perspective for Pharmaceutical Excipients by Type - Percentage Breakdown of Value Sales for Organic Chemicals, Inorganic Chemicals and Other Types for the Years 2012, 2020 & 2027
    • TABLE 79: UK Current & Future Analysis for Pharmaceutical Excipients by Formulation - Oral, Topical, Parenteral and Other Formulations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 80: UK Historic Review for Pharmaceutical Excipients by Formulation - Oral, Topical, Parenteral and Other Formulations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 81: UK 15-Year Perspective for Pharmaceutical Excipients by Formulation - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral and Other Formulations for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Current & Future Analysis for Pharmaceutical Excipients by Type - Organic Chemicals, Inorganic Chemicals and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 83: Rest of Europe Historic Review for Pharmaceutical Excipients by Type - Organic Chemicals, Inorganic Chemicals and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 84: Rest of Europe 15-Year Perspective for Pharmaceutical Excipients by Type - Percentage Breakdown of Value Sales for Organic Chemicals, Inorganic Chemicals and Other Types for the Years 2012, 2020 & 2027
    • TABLE 85: Rest of Europe Current & Future Analysis for Pharmaceutical Excipients by Formulation - Oral, Topical, Parenteral and Other Formulations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Rest of Europe Historic Review for Pharmaceutical Excipients by Formulation - Oral, Topical, Parenteral and Other Formulations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 87: Rest of Europe 15-Year Perspective for Pharmaceutical Excipients by Formulation - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral and Other Formulations for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 88: Asia-Pacific Current & Future Analysis for Pharmaceutical Excipients by Type - Organic Chemicals, Inorganic Chemicals and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Asia-Pacific Historic Review for Pharmaceutical Excipients by Type - Organic Chemicals, Inorganic Chemicals and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 90: Asia-Pacific 15-Year Perspective for Pharmaceutical Excipients by Type - Percentage Breakdown of Value Sales for Organic Chemicals, Inorganic Chemicals and Other Types for the Years 2012, 2020 & 2027
    • TABLE 91: Asia-Pacific Current & Future Analysis for Pharmaceutical Excipients by Formulation - Oral, Topical, Parenteral and Other Formulations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Asia-Pacific Historic Review for Pharmaceutical Excipients by Formulation - Oral, Topical, Parenteral and Other Formulations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 93: Asia-Pacific 15-Year Perspective for Pharmaceutical Excipients by Formulation - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral and Other Formulations for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 94: Rest of World Current & Future Analysis for Pharmaceutical Excipients by Type - Organic Chemicals, Inorganic Chemicals and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Rest of World Historic Review for Pharmaceutical Excipients by Type - Organic Chemicals, Inorganic Chemicals and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 96: Rest of World 15-Year Perspective for Pharmaceutical Excipients by Type - Percentage Breakdown of Value Sales for Organic Chemicals, Inorganic Chemicals and Other Types for the Years 2012, 2020 & 2027
    • TABLE 97: Rest of World Current & Future Analysis for Pharmaceutical Excipients by Formulation - Oral, Topical, Parenteral and Other Formulations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Rest of World Historic Review for Pharmaceutical Excipients by Formulation - Oral, Topical, Parenteral and Other Formulations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 99: Rest of World 15-Year Perspective for Pharmaceutical Excipients by Formulation - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral and Other Formulations for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 42